News Focus
News Focus
icon url

DewDiligence

11/10/20 9:07 AM

#235533 RE: jbog #234891

BMY sells $7B of 3-30yr notes—to fund MYOK acquisition:

https://www.businesswire.com/news/home/20201109006199/en

• $1.5B of 3yr notes paying 0.537%
• $1.0B of 5yr notes paying 0.750%
• $1.0B of 7yr notes paying 1.125%
• $1.25B of 10yr notes paying 1.450%
• $0.75B of 20yr notes paying 2.350%
• $1.5B of 30yr notes paying 2.550%

At these rates, BMY should borrow as much as possible.
icon url

DewDiligence

03/19/21 8:37 AM

#237490 RE: jbog #234891

BMY PDUFA date for Mavacamten is 1/28/22:

https://www.businesswire.com/news/home/20210319005189/en

Mavacamten is the drug BMY got in the $13.1B acquisition of MYOK in Oct 2020 (#msg-158698900).